US7763609B2
(en)
|
2003-12-15 |
2010-07-27 |
Schering Corporation |
Heterocyclic aspartyl protease inhibitors
|
US7700603B2
(en)
|
2003-12-15 |
2010-04-20 |
Schering Corporation |
Heterocyclic aspartyl protease inhibitors
|
WO2006138265A2
(en)
|
2005-06-14 |
2006-12-28 |
Schering Corporation |
Heterocyclic aspartyl protease inhibitors, preparation and use thereof
|
CA2609582A1
(en)
|
2005-06-14 |
2006-12-28 |
Schering Corporation |
Aspartyl protease inhibitors
|
KR101052122B1
(ko)
|
2005-10-25 |
2011-07-26 |
시오노기세야쿠 가부시키가이샤 |
아미노디히드로티아진 유도체
|
MX2008015956A
(es)
|
2006-06-12 |
2009-01-09 |
Schering Corp |
Inhibidores heterociclicos de aspartil-proteasa.
|
JP5383483B2
(ja)
|
2007-04-24 |
2014-01-08 |
塩野義製薬株式会社 |
アルツハイマー症治療用医薬組成物
|
AU2008245082B8
(en)
|
2007-04-24 |
2012-09-13 |
Shionogi & Co., Ltd. |
Aminodihydrothiazine derivatives substituted with a cyclic group
|
CN101910143B
(zh)
|
2008-01-18 |
2013-08-21 |
卫材R&D管理有限公司 |
稠合的氨基二氢噻嗪衍生物
|
EP2283016B1
(en)
|
2008-04-22 |
2014-09-24 |
Merck Sharp & Dohme Corp. |
Thiophenyl-substituted 2-imino-3-methyl pyrrolo pyrimidinone compounds as bace-1 inhibitors, compositions, and their use
|
TWI431004B
(zh)
*
|
2008-05-02 |
2014-03-21 |
Lilly Co Eli |
Bace抑制劑
|
US8637504B2
(en)
|
2008-06-13 |
2014-01-28 |
Shionogi & Co., Ltd. |
Sulfur-containing heterocyclic derivative having beta secretase inhibitory activity
|
US8501733B2
(en)
*
|
2008-07-28 |
2013-08-06 |
Eisai R&D Management Co., Ltd. |
Spiroaminodihydrothiazine derivatives
|
EP2324032B1
(en)
|
2008-08-19 |
2014-10-01 |
Vitae Pharmaceuticals, Inc. |
Inhibitors of beta-secretase
|
PE20110805A1
(es)
|
2008-09-11 |
2011-11-09 |
Amgen Inc |
Compuestos con anillos espiro-triciclicos como moduladores de beta-secretasas y metodos de uso
|
KR20110076965A
(ko)
*
|
2008-09-30 |
2011-07-06 |
에자이 알앤드디 매니지먼트 가부시키가이샤 |
신규한 축합 아미노 디하이드로티아진 유도체
|
WO2010047372A1
(ja)
|
2008-10-22 |
2010-04-29 |
塩野義製薬株式会社 |
Bace1阻害活性を有する2-アミノピリミジン-4-オンおよび2-アミノピリジン誘導体
|
CN102348698B
(zh)
|
2009-03-13 |
2015-06-03 |
生命医药公司 |
β-分泌酶的抑制剂
|
GB0912778D0
(en)
|
2009-07-22 |
2009-08-26 |
Eisai London Res Lab Ltd |
Fused aminodihydro-oxazine derivatives
|
GB0912777D0
(en)
|
2009-07-22 |
2009-08-26 |
Eisai London Res Lab Ltd |
Fused aminodihydropyrimidone derivatives
|
WO2011044184A1
(en)
|
2009-10-08 |
2011-04-14 |
Schering Corporation |
Pentafluorosulfur imino heterocyclic compounds as bace-1 inhibitors, compositions, and their use
|
UA108363C2
(uk)
|
2009-10-08 |
2015-04-27 |
|
Похідні імінотіадіазиндіоксиду як інгібітори bace, композиція на їх основі і їх застосування
|
AU2013234422B9
(en)
*
|
2009-10-08 |
2014-07-03 |
Merck Sharp & Dohme Llc |
Iminothiadiazine dioxide compounds as BACE inhibitors, compositions, and their use
|
US8563543B2
(en)
|
2009-10-08 |
2013-10-22 |
Merck Sharp & Dohme Corp. |
Iminothiadiazine dioxide compounds as bace inhibitors, compositions, and their use
|
WO2011044185A2
(en)
|
2009-10-08 |
2011-04-14 |
Schering Corporation |
Pentafluorosulfur imino heterocyclic compounds as bace-1 inhibitors, compositions, and their use
|
WO2011070781A1
(ja)
|
2009-12-09 |
2011-06-16 |
塩野義製薬株式会社 |
置換アミノチアジン誘導体
|
WO2011071057A1
(ja)
*
|
2009-12-09 |
2011-06-16 |
塩野義製薬株式会社 |
含硫黄複素環誘導体を含有するアルツハイマー症の治療用または予防用医薬組成物
|
EP2511268B2
(en)
|
2009-12-11 |
2021-02-17 |
Shionogi & Co., Ltd. |
Oxazine derivative
|
EP2518059A4
(en)
|
2009-12-24 |
2013-05-29 |
Shionogi & Co |
4-AMINO-1,3-THIAZINE OR OXAZINE DERIVATIVE
|
WO2011106414A1
(en)
|
2010-02-24 |
2011-09-01 |
Dillard Lawrence W |
Inhibitors of beta-secretase
|
US8497264B2
(en)
|
2010-03-15 |
2013-07-30 |
Amgen Inc. |
Amino-oxazines and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use
|
EP2547685A1
(en)
|
2010-03-15 |
2013-01-23 |
Amgen Inc. |
Spiro-tetracyclic ring compounds as beta - secretase modulators
|
KR101730937B1
(ko)
|
2010-06-09 |
2017-04-27 |
얀센 파마슈티카 엔.브이. |
베타-세크레타아제(bace) 저해제로 유용한 5,6-디하이드로-2h-[1,4]옥사진-3-일-아민 유도체
|
MX2012014382A
(es)
*
|
2010-06-09 |
2013-01-29 |
Janssen Pharmaceutica Nv |
Derivados de 5-amino-3, 6-dihidro-1h-pirazin-2-ona utiles como inhibidores de beta-secretasa (bace).
|
US8921363B2
(en)
|
2010-08-05 |
2014-12-30 |
Amgen Inc. |
Derivatives of 1 H-isoindol-3-amine, 1 H-iso-aza-indol-3amine, 3,4-dihydroisoquinolin-1-amine, and 1,4-dihydroisoquinolin-3-amine as beta-secretase inhibitors
|
JP5766198B2
(ja)
|
2010-10-29 |
2015-08-19 |
塩野義製薬株式会社 |
縮合アミノジヒドロピリミジン誘導体
|
CN103261199A
(zh)
|
2010-10-29 |
2013-08-21 |
盐野义制药株式会社 |
萘啶衍生物
|
EP2643325A1
(en)
|
2010-11-23 |
2013-10-02 |
Amgen Inc. |
Spiro-amino-imidazolone and spiro-amino-dihydro-pyrimidinone compounds as beta-secretase modulators and methods of use
|
EA022409B1
(ru)
|
2010-12-22 |
2015-12-30 |
Янссен Фармацевтика Нв |
Производные 5,6-дигидроимидазо[1,2-а]пиразин-8-иламина, пригодные в качестве ингибиторов бета-секретазы (васе)
|
GB201100181D0
(en)
|
2011-01-06 |
2011-02-23 |
Eisai Ltd |
Fused aminodihydrothiazine derivatives
|
SG191710A1
(en)
|
2011-01-21 |
2013-08-30 |
Eisai R&D Man Co Ltd |
Methods and compounds useful in the synthesis of fused aminodihydrothiazine derivatives
|
GB201101139D0
(en)
|
2011-01-21 |
2011-03-09 |
Eisai Ltd |
Fused aminodihydrothiazine derivatives
|
GB201101140D0
(en)
|
2011-01-21 |
2011-03-09 |
Eisai Ltd |
Fused aminodihydrothiazine derivatives
|
EP2673279A1
(en)
|
2011-02-07 |
2013-12-18 |
Amgen Inc. |
5-amino-oxazepine and 5-amino-thiazepane compounds as beta-secretase antagonists and methods of use
|
WO2012112462A1
(en)
|
2011-02-15 |
2012-08-23 |
Amgen Inc. |
Spiro-amino-imidazo-fused heterocyclic compounds as beta-secretase modulators and methods of use
|
HUE026338T2
(en)
|
2011-03-01 |
2016-05-30 |
Janssen Pharmaceutica Nv |
Beta-secretase (BACE) inhibitors 6,7-dihydro-pyrazolo [1,5-a] pyrazin-4-ylamine derivatives
|
AU2012224632B2
(en)
|
2011-03-09 |
2016-06-16 |
Janssen Pharmaceutica Nv |
3,4-dihydro-pyrrolo[1,2-a]pyrazin-1-ylamine derivatives useful as inhibitors of beta-secretase (BACE)
|
EP2694489B1
(en)
|
2011-04-07 |
2017-09-06 |
Merck Sharp & Dohme Corp. |
C5-c6 oxacyclic-fused thiadiazine dioxide compounds as bace inhibitors, compositions, and their use
|
WO2012138590A1
(en)
|
2011-04-07 |
2012-10-11 |
Merck Sharp & Dohme Corp. |
Pyrrolidine-fused thiadiazine dioxide compounds as bace inhibitors, compositions, and their use
|
CN103596939A
(zh)
*
|
2011-04-13 |
2014-02-19 |
默沙东公司 |
作为bace抑制剂的5-取代的亚氨基噻嗪类及其单和二氧化物、组合物及其应用
|
MX2013011947A
(es)
|
2011-04-13 |
2014-01-16 |
Merck Sharp & Dohme |
Iminotiazinas 5-sustituidas y sus monoxidos y dioxidos como inhibidores de la enzima que encinde la proteina precursora amiloide en el sitio beta, composiciones y su uso.
|
EP2703401A4
(en)
|
2011-04-26 |
2014-12-03 |
Shionogi & Co |
PYRIDINE DERIVATIVE AND BACE-1 HEMMER THEREOF
|
WO2012147763A1
(ja)
|
2011-04-26 |
2012-11-01 |
塩野義製薬株式会社 |
オキサジン誘導体およびそれを含有するbace1阻害剤
|
AU2012298983A1
(en)
|
2011-08-22 |
2014-02-27 |
Merck Sharp & Dohme Corp. |
2-spiro-substituted iminothiazines and their mono-and dioxides as BACE inhibitors, compositions and their use
|
JP2014526560A
(ja)
|
2011-09-21 |
2014-10-06 |
アムジエン・インコーポレーテツド |
β‐セクレターゼ調節因子としてのアミノオキサジン化合物およびアミノジヒドロチアジン化合物および使用方法
|
TWI557112B
(zh)
|
2012-03-05 |
2016-11-11 |
百靈佳殷格翰國際股份有限公司 |
β-分泌酶抑制劑
|
TW201422592A
(zh)
|
2012-08-27 |
2014-06-16 |
Boehringer Ingelheim Int |
β-分泌酶抑制劑
|
US9290477B2
(en)
|
2012-09-28 |
2016-03-22 |
Vitae Pharmaceuticals, Inc. |
Inhibitors of β-secretase
|
WO2014059185A1
(en)
|
2012-10-12 |
2014-04-17 |
Amgen Inc. |
Amino - dihydrothiazine and amino - dioxido dihydrothiazine compounds as beta-secretase antagonists and methods of use
|
US9416129B2
(en)
|
2012-10-17 |
2016-08-16 |
Merck Sharp & Dohme Corp. |
Tricyclic substituted thiadiazine dioxide compounds as BACE inhibitors, compositions and their use
|
US9422277B2
(en)
|
2012-10-17 |
2016-08-23 |
Merck Sharp & Dohme Corp. |
Tricyclic substituted thiadiazine dioxide compounds as BACE inhibitors, compositions and their use
|
US9540359B2
(en)
|
2012-10-24 |
2017-01-10 |
Shionogi & Co., Ltd. |
Dihydrooxazine or oxazepine derivatives having BACE1 inhibitory activity
|
WO2014078314A1
(en)
|
2012-11-15 |
2014-05-22 |
Amgen Inc. |
Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use
|
WO2014127042A1
(en)
|
2013-02-12 |
2014-08-21 |
Buck Institute For Research On Aging |
Hydantoins that modulate bace-mediated app processing
|
JP6389830B2
(ja)
|
2013-03-01 |
2018-09-12 |
アムジエン・インコーポレーテツド |
ベータ−セクレターゼ阻害剤としてのパーフルオロ化5,6−ジヒドロ−4h−1,3−オキサジン−2−アミン化合物および使用方法
|
US9085576B2
(en)
|
2013-03-08 |
2015-07-21 |
Amgen Inc. |
Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use
|
TWI593692B
(zh)
*
|
2013-03-12 |
2017-08-01 |
美國禮來大藥廠 |
四氫吡咯并噻嗪化合物
|
KR102243133B1
(ko)
|
2013-06-12 |
2021-04-22 |
얀센 파마슈티카 엔.브이. |
베타-세크레타제(bace) 저해제로서의 4-아미노-6-페닐-6,7-디하이드로[1,2,3]트리아졸로[1,5-a]피라진 유도체
|
ES2697684T3
(es)
|
2013-06-12 |
2019-01-25 |
Janssen Pharmaceutica Nv |
Derivados de 4-amino-6-fenil-5,6-dihidroimidazo[1,5 a]pirazina como inhibidores de beta-secretasa (BACE)
|
US9834559B2
(en)
|
2013-06-12 |
2017-12-05 |
Janssen Pharmaceutica Nv |
4-Amino-6-phenyl-5,6-dihydroimidazo[1,5-a]pyrazin-3(2H)-one derivatives as inhibitors of beta-secretase (BACE)
|
JO3318B1
(ar)
*
|
2013-06-18 |
2019-03-13 |
Lilly Co Eli |
مثبطات bace
|
US9096615B2
(en)
|
2013-07-30 |
2015-08-04 |
Amgen Inc. |
Bridged bicyclic amino thiazine dioxide compounds as inhibitors of beta-secretase and methods of use thereof
|
CN106029639B
(zh)
*
|
2014-02-19 |
2019-01-08 |
H.隆德贝克有限公司 |
治疗阿尔茨海默病的bace1抑制剂的2-氨基-3,5,5-三氟-3,4,5,6-四氢吡啶
|
WO2016022724A1
(en)
|
2014-08-08 |
2016-02-11 |
Amgen Inc. |
Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use
|
KR20170095881A
(ko)
|
2014-12-18 |
2017-08-23 |
얀센 파마슈티카 엔.브이. |
베타―세크레타제의 2,3,4,5―테트라히드로피리딘―6―아민 및 3,4―디히드로―2h―피롤―5―아민 화합물 억제제
|
CN107257795A
(zh)
*
|
2015-03-19 |
2017-10-17 |
伊莱利利公司 |
选择性bace1抑制剂
|
US10246429B2
(en)
|
2015-08-06 |
2019-04-02 |
Amgen Inc. |
Vinyl fluoride cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use
|
WO2017061534A1
(en)
|
2015-10-08 |
2017-04-13 |
Shionogi & Co., Ltd. |
Dihydrothiazine derivatives
|
JP2019524788A
(ja)
*
|
2016-08-11 |
2019-09-05 |
イーライ リリー アンド カンパニー |
アミノチアジンおよびbace1阻害剤としてのそれらの使用
|
CA3047288A1
(en)
|
2016-12-15 |
2018-06-21 |
Amgen Inc. |
Thiazine derivatives as beta-secretase inhibitors and methods of use
|
MX2019007104A
(es)
|
2016-12-15 |
2019-11-05 |
Amgen Inc |
Derivados de dioxido de 1,4-tiazina y dioxido de 1,2,4-tiadiazina como inhibidores de beta-secretasa y metodos de uso.
|
EP3555106B1
(en)
|
2016-12-15 |
2022-03-09 |
Amgen Inc. |
Bicyclic thiazine and oxazine derivatives as beta-secretase inhibitors and methods of use
|
WO2018112086A1
(en)
|
2016-12-15 |
2018-06-21 |
Amgen Inc. |
Cyclopropyl fused thiazine derivatives as beta-secretase inhibitors and methods of use
|
MA52722A
(fr)
|
2016-12-15 |
2021-04-14 |
Amgen Inc |
Dérivés d'oxazine en tant qu'inhibiteurs de bêta-sécrétase et procédés d'utilisation
|
AR110747A1
(es)
*
|
2017-01-27 |
2019-05-02 |
Lilly Co Eli |
Compuestos de 5-metil-1,2,4-oxadiazol-3-ilo
|
JP7353708B2
(ja)
|
2018-04-27 |
2023-10-02 |
塩野義製薬株式会社 |
選択的bace1阻害活性を有するテトラヒドロピラノオキサジン誘導体
|